Literature DB >> 10805250

Direct MS-MS identification of isoxsuprine-glucuronide in post-administration equine urine.

J M Bosken1, A F Lehner, A Hunsucker, J D Harkins, W E Woods, W Karpiesiuk, W G Carter, J Boyles, M Fisher, T Tobin.   

Abstract

Isoxsuprine is routinely recovered from enzymatically-hydrolyzed, post-administration urine samples as parent isoxsuprine in equine forensic science. However, the specific identity of the material in horse urine from which isoxsuprine is recovered has never been established, although it has long been assumed to be a glucuronide conjugate (or conjugates) of isoxsuprine. Using ESI/MS/MS positive mode as an analytical tool, urine samples collected 4-8 h after isoxsuprine administration yielded a major peak at m/z 554 that was absent from control samples and resisted fragmentation to daughter ions. Titration of this material with increasing concentrations of sodium acetate yielded m/z peaks consistent with the presence of monosodium and disodium isoxsuprine-glucuronide complexes, suggesting that the starting material was a dipotassium-isoxsuprine-glucuronide complex. Electrospray ionization mass spectrometry negative mode disclosed the presence of a m/z 476 peak that declined following enzymatic hydrolysis and resulted in the concomitant appearance of peaks at m/z 300 and 175. The resulting peaks were consistent with the presence of isoxsuprine (m/z 300) and a glucuronic acid residue (m/z 175). Examination of the daughter ion spectrum of this putative isoxsuprine-glucuronide m/z 476 peak showed overlap of many peaks with those of similar spectra of authentic morphine-3- and morphine-6-glucuronides, suggesting they were derived from glucuronic acid conjugation. These data suggest that isoxsuprine occurs in post-administration urine samples as an isoxsuprine-glucuronide conjugate and also, under some circumstances, as an isoxsuprine-glucuronide-dipotassium complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805250      PMCID: PMC1189594     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  7 in total

1.  Determination of isoxsuprine in equine plasma by high-performance liquid chromatography with electrochemical detection.

Authors:  A Hashem; B Lubczyk
Journal:  J Chromatogr       Date:  1991-01-18

2.  Tocolytic drugs for use in veterinary obstetrics.

Authors:  L Ménard
Journal:  Can Vet J       Date:  1984-10       Impact factor: 1.008

3.  Effect of beta adrenergic receptor blockade on skeletal muscle vasodilatation produced by isoxsuprine and nylidrin.

Authors:  E S Manley; J W Lawson
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-09

4.  The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: a double blind study.

Authors:  A S Turner; C M Tucker
Journal:  Equine Vet J       Date:  1989-09       Impact factor: 2.888

5.  Hydromorphone-3-glucuronide: biochemical synthesis and preliminary pharmacological evaluation.

Authors:  A W Wright; M L Nocente; M T Smith
Journal:  Life Sci       Date:  1998       Impact factor: 5.037

6.  Prolonged presence of isoxsuprine in equine serum after oral administration.

Authors:  G Pompa; F Caloni; M Montana; C Pasqualucci
Journal:  Xenobiotica       Date:  1994-04       Impact factor: 1.908

7.  Screening and confirmatory analysis of beta-agonists, beta-antagonists and their metabolites in horse urine by capillary gas chromatography-mass spectrometry.

Authors:  M C Dumasia; E Houghton
Journal:  J Chromatogr       Date:  1991-04-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.